Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma

Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma

While most patients with follicular lymphoma (FL) have excellent outcomes with frontline chemoimmunotherapy (CIT), a subset of patients will experience early progression, which is associated with poor subsequent outcomes. Novel biomarkers are needed to identify high-risk patients earlier. We hypothe...

Full description

Bibliographic Details
Main Authors: Reid W. Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Gabriela Spilberg, Matthew Robertson, Eleanor Taranto, Gulrayz Ahmed, Matthew Chase, Erin Jeter, Inhye E. Ahn, Jennifer R. Brown, Jennifer Crombie, Matthew S. Davids, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Gilles Salles, Andrew D. Zelenetz, Philippe Armand, Heiko Schöder, Heather Jacene
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000826

Internet

http://journals.lww.com/10.1097/HS9.0000000000000826

Similar Items